# Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

> **NCT05590117** · EARLY_PHASE1 · UNKNOWN · sponsor: **Tanta University** · enrollment: 48 (estimated)

## Conditions studied

- Colo-rectal Cancer
- Neuropathy;Peripheral
- Mucositis

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** Placebo
- **DRUG:** FOLFOX-6 regimen

## Key facts

- **NCT ID:** NCT05590117
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-11
- **Primary completion:** 2023-10-11
- **Final completion:** 2024-10-11
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590117, "Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT05590117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*